Reglan (metoclopramide) is a prescription medication that speeds up the movement of food through your stomach and upper digestive tract. It’s primarily used to treat gastroparesis in people with diabetes and to prevent nausea and vomiting from chemotherapy or surgery. The FDA recommends using it for no longer than 12 weeks due to the risk of a serious, potentially permanent movement disorder.
Gastroparesis: The Primary Use
Gastroparesis is a condition where your stomach takes too long to empty its contents into the small intestine. In people with diabetes, nerve damage can slow this process down significantly, leading to nausea, vomiting, bloating, and feeling full after just a few bites. Reglan works by strengthening the muscular contractions in your upper digestive tract, helping food move through more quickly.
For diabetic gastroparesis, the typical course of treatment is 2 to 8 weeks. Reglan is usually taken four times a day, 30 minutes before meals and at bedtime, so the medication is active when food enters the stomach. It’s available as tablets, an oral liquid, and an injectable form for situations where swallowing pills isn’t practical.
Nausea and Vomiting Prevention
Reglan has two additional FDA-approved uses related to nausea. The first is preventing vomiting caused by cancer chemotherapy drugs. Certain chemotherapy regimens are highly likely to trigger nausea, and Reglan can be given intravenously before treatment to reduce that risk. The second is preventing nausea and vomiting after surgery, particularly when a nasogastric tube (a tube through the nose into the stomach) isn’t a good option for the patient.
Acid Reflux That Won’t Respond to Other Treatments
Reglan is also approved for gastroesophageal reflux disease (GERD) in adults who haven’t improved with standard treatments like antacids or proton pump inhibitors. By speeding up stomach emptying, it reduces the amount of time acidic contents sit in the stomach and can splash back into the esophagus. Treatment for reflux typically lasts 4 to 12 weeks, with the same hard cap of 12 weeks maximum.
Off-Label Use for Migraines
One of the more common off-label uses for Reglan is treating acute migraines, especially in emergency departments. A randomized clinical trial published in the Annals of Emergency Medicine found that patients who received intravenous metoclopramide experienced an average pain reduction of about 4.7 points on a 10-point scale within one hour. Interestingly, higher doses (20 mg and 40 mg) didn’t perform meaningfully better than the standard 10 mg dose. About 16% to 21% of patients remained pain-free 48 hours later, regardless of dose. It’s often paired with an antihistamine to prevent the restlessness and muscle stiffness the drug can cause.
Off-Label Use for Milk Supply
Reglan is sometimes prescribed off-label to help breastfeeding parents increase milk production. It works by blocking dopamine, which in turn raises levels of prolactin, the hormone that drives milk production. The Academy of Breastfeeding Medicine identifies metoclopramide as one of the two most commonly used medications for this purpose. The typical dose is 10 mg taken three to four times a day. However, this use carries the same risk of side effects as any other use, including mood changes, anxiety, and drowsiness, which can be especially challenging during the postpartum period.
Common Side Effects
The most frequent side effects are related to the central nervous system. Roughly 10% of people taking Reglan experience restlessness, drowsiness, or fatigue. Some people describe a jittery, can’t-sit-still feeling that’s distinct from ordinary anxiety. Acute muscle spasms (dystonic reactions) occur in about 1 in 500 patients at standard doses and are more common in younger adults. These episodes can involve involuntary movements of the face, neck, or tongue and typically resolve once the medication is stopped or treated.
The Black Box Warning on Tardive Dyskinesia
Reglan carries the FDA’s most serious safety warning. Long-term use can cause tardive dyskinesia, a movement disorder involving repetitive, involuntary movements like lip smacking, tongue thrusting, or grimacing. This condition is often irreversible, meaning it may not go away even after the drug is stopped, though some patients do see improvement over time. There is no reliable treatment for it.
The risk increases with longer use and higher total doses, which is why the FDA draws a firm line at 12 weeks. Elderly patients, women, and people with diabetes appear to face higher risk, though it’s not possible to predict exactly who will develop the condition. If you notice any unusual facial or body movements while taking Reglan, that’s a reason to contact your prescriber promptly.
Who Should Not Take Reglan
Reglan is not safe for everyone. It should not be used if you have:
- A bowel obstruction, perforation, or bleeding, because speeding up gut movement in these situations can cause serious harm
- A history of tardive dyskinesia or a previous dystonic reaction to the drug
- Epilepsy, as it can increase the frequency and severity of seizures
- Pheochromocytoma (a rare adrenal gland tumor), because the drug can trigger a dangerous spike in blood pressure by causing the tumor to release stress hormones
It should also be used cautiously alongside other medications that affect dopamine or cause similar movement-related side effects, since combining them raises the risk of neurological complications.
What to Expect During Treatment
Most people take Reglan for a defined, short period. For gastroparesis, you may notice improvement in nausea and fullness within the first few days. Your prescriber will likely reassess your symptoms at regular intervals to determine whether the benefit justifies continued use. If the drug isn’t providing clear relief within a few weeks, continuing it generally isn’t recommended given the risks.
Because of the 12-week limit, Reglan is not a long-term management strategy for chronic digestive conditions. It’s typically used as a bridge, providing symptom relief while other approaches (dietary changes, blood sugar management, or alternative medications) are explored.